Regeneron Pharmaceuticals
Price & Volume
Stats
See more52W Range | $641.17-$1,209.64 |
Market Cap | $76.5B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $14.2B |
Revenue Growth (YoY) | 10.3% |
Gross Profit (12 Mos) | $7B |
Diluted EPS | $38.31 |
News
See moreYahoo Finance • 7 hours ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN
Yahoo Finance • 2 days ago
Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – REGN
Yahoo Finance • 2 days ago
Regeneron Pharmaceuticals (REGN) Faces Mounting Pressure on Sales, Legal Fronts – Hagens Berman
About
CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
CFO | Mr. Christopher R. Fenimore CPA |
Address | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15,106 |
